Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Get access to latest Egypt pharmaceutical tenders and bids. Find business opportunities and business intelligence for Egypt pharmaceutical tenders, Egypt pharmaceuticals bids contracts, pharma public procurement notices, Egypt drugs tenders, Egypt medicine tenders, Egypt generic medicine tenders, pharmaceutical market reports, pharmaceutical market intelligence. Find Egypt tenders, bids, procurement, RFPs, RFQs, ICBs. Search for Egypt pharmaceutical tenders online. The Economy of Egypt used to be a highly centralized economy, focused on import substitution under president Gamal Abdel Nasser. During the rule of president Abdel Fattah el-Sisi, the economy follows Egypt's 2030 Vision. The policy is aimed at diversifying Egypt's economy. The country's economy became the second largest in Africa after Nigeria regarding nominal GDP, the sixth largest in the Middle East, and 36th in worldwide ranking as of 2021. Since the 2000s, the pace of structural reforms (including fiscal and monetary policies, taxation, privatisation and new business legislation) helped Egypt move towards a more market-oriented economy and prompted increased foreign investment. The reforms and policies have strengthened macroeconomic annual growth results. As Egypt's economy healed, other prominent issues like unemployment and poverty began to decline significantly. The country benefits from political stability; its proximity to Europe, and increased exports. The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020 and showed a compound annual growth rate (CAGR) of 1.8%.